'Selfish' Bacteria Link IBD And Gut Microbiota

The discovery of unusual foraging activity in bacteria species populating our gut may explain how conditions like Inflammatory Bowel Disease (IBD) link to changes in the populations of bacteria in our gut. IBD affects 1 in every 250 people but its causes are unknown. Studies have shown that IBD patients have a different profile of gut microbes, which is called dysbiosis.
All of us have trillions of beneficial bacteria in our gut, but the combination of different species, known as the microbiome, varies. A crucial question has been whether IBD causes our microbiome to change, or whether an imbalanced microbiome could be triggering IBD. And exactly how does one affect the other? We need to study these interactions to define new targets for therapeutics.
Nathalie Juge and colleagues at the Institute of Food Research (IFR) have been trying to answer these questions by looking at the environment in which gut bacteria grow mucus.
Mucus covers the lining of our gut and provides an ideal environment for gut bacteria to grow by providing them with a rich source of sugars. However not all bacteria can consume mucus, and it’s been shown recently that IBD patients had a higher proportion of specific mucus-degrading bacteria called Ruminococcus gnavus, common gut bacteria found in most individuals.
Mucus is made up of long molecules, called mucins, which consist of protein chains, decorated with sugars, and usually capped with sialic acid, a sugar residue widely distributed in animal tissues. To use mucins, bacteria first have to remove the sialic acid. Once this is done, the sialic acid becomes available as a nutrient source for the whole of the bacterial community in the mucosal environment.
This means mucin-degrading bacteria have an important role in the whole bacterial community, so the researchers set out to work out what makes them effective.
Previously, the researchers found that R. gnavus’s ability to degrade mucins depended on the type of strain they were working with. So they then compared the genome sequences of these strains to identify which genes were behind the mucus-degrading abilities.
In a follow-up study, published in the journal Nature Communications, they found a surprising result. The cleavage enzyme allowing R. gnavus strains to grow on mucins, instead of releasing free sialic acid, chemically modifies it upon cleavage, providing these bacteria with a preferential source of nutrient.
This suggests a “selfish” behavior where instead of sharing free sialic acid with other bacteria, R. gnavus mucin-degrader strains can use the modified sialic acid themselves.
This unusual activity hadn’t been seen in any other gut bacteria before. But having identified the enzyme, a bioinformatics screen found it in 11% of other bacteria. And the enzyme is also enriched in IBD patients, which agrees with previous studies showing an increased proportion of R. gnavus in IBD patients.

Comments

Post a Comment

Popular posts from this blog

Fussy eaters: the favoured food of Salmonella

Image
As antibiotic resistance increases the search for new anti-bacterial treatments becomes more and more important. One way to design anti-bacterials is to find specific biochemical pathways that the bacteria require to survive, and develop drugs that block off these pathways. Some pathways are better targets than others and for  Salmonella bacteria it was thought that pathways dealing with nutrient metabolises would be a lost cause. Salmonella lives in the intestine, which hosts a whole variety of different nutrients, so surely preventing the bacteria from using a specific one wouldn’t cause them much undue distress. It’s been found, however, that as they grow and spread in the inflamed intestine the bacteria are heavily reliant on one particular nutrient: fructose-asparagine. The chemical structure of fructose-asparagine, image from the reference. The importance of fructose-asparagine metabolism was originally discovered durin...
Read more

Timing is key for bacteria surviving antibiotics

For bacteria facing a dose of antibiotics, timing might be the key to evading destruction. In a series of experiments, Princeton researchers found that cells that repaired DNA damaged by antibiotics before resuming growth had a much better chance of surviving treatment. When antibiotics hit a population of bacteria, often a small fraction of "persister" cells survive to pose a threat of recurrent infection. Unlike bacteria with genetic resistance to antibiotics, evidence suggests that persisters stay alive in part by stalling cellular processes targeted by the drugs. In a new study, Princeton researchers examined a class of antibiotics that target bacterial DNA. In bacterial populations, some cells repair damaged DNA before resuming growth, and others resume growth before making repairs. The researchers found that those that make repairs before resuming growth generally are the ones that survive as persisters. The research advances a long-term goal to make ...
Read more